Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03920956 · ClinicalTrials.gov registry record · NA

24-Hour Ambulatory Blood Pressure Monitoring in Community Pharmacies

A NA study of Hypertension, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT03920956 is a NA study of Hypertension that has completed, run by Virginia Commonwealth University. The registered enrollment target is 53 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03920956, a NA study of Hypertension, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

This study is designed to explore the feasibility of providing 24-hour ambulatory blood pressure monitoring in community pharmacies. The investigators hypothesize it will be feasible for community pharmacies to provide the service to assist medical providers in the diagnosing and management of high blood pressure. The investigators will also survey participants regarding their experience with the service as well as conduct interviews with participating pharmacists and medical providers to understand their views and opinions on the feasibility of the service.

Conditions Studied

Interventions

  • OTHER ABPM service by Pharmacists

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2019-07-24
Est. Completion 2020-01-24
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT03920956

The ClinicalTrials.gov registry entry for NCT03920956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which ABPM service by Pharmacists is the first listed.

NCT03920956 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03920956 about?

NCT03920956 is a clinical study titled "24-Hour Ambulatory Blood Pressure Monitoring in Community Pharmacies". This study is designed to explore the feasibility of providing 24-hour ambulatory blood pressure monitoring in community pharmacies. The investigators hypothesize it will be feasible for community pharmacies to provide the service to assist medical providers in the diagnosing and management of high ...

What is the current status of trial NCT03920956?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2019-07-24. Estimated completion is 2020-01-24.

What conditions does trial NCT03920956 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT03920956?

The interventions under investigation include: ABPM service by Pharmacists (OTHER).

Who is sponsoring clinical trial NCT03920956?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03920956 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.